--- title: "ALCON INC (ALC) stock listing, news and investor profile" url: "https://aibio.space/companies/alcon/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ALCON INC (NYSE: ALC), United States. Listing facts, related biotech companies and news on aibio.space." --- ALC ALCON INC NYSE · United States # ALCON INC (ALC) news ALCON INC is a public biotech or pharmaceutical company listed on NYSE under the ticker ALC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest ALCON INC news We have not published a story on ALCON INC yet. When there is news, it will appear here. ## ALCON INC at a glance - **Ticker**: ALC - **Listing**: NYSE - **Country**: United States - **Cash, Dec 31, 2010**: $3.41 billion ### Related companies - [Cytosorbents](https://aibio.space/companies/cytosorbents/) NASDAQ: CTSO - [BillionToOne](https://aibio.space/companies/billiontoone/) NASDAQ: BLLN - [Bioventus](https://aibio.space/companies/bioventus/) NASDAQ: BVS - [Heartflow](https://aibio.space/companies/heartflow/) NASDAQ: HTFL - [ASTROTECH](https://aibio.space/companies/astrotech/) NASDAQ: ASTC - [INTEGRA LIFESCIENCES HOLDINGS CORP](https://aibio.space/companies/integra-lifesciences/) NASDAQ: IART - [Stereotaxis](https://aibio.space/companies/stereotaxis/) NYSE: STXS - [RAPID MICRO BIOSYSTEMS, INC.](https://aibio.space/companies/rapid-micro-biosystems/) NASDAQ: RPID ### Also on NYSE - [LABCORP HOLDINGS INC.](https://aibio.space/companies/labcorp/) LH - [Flyte Aviation](https://aibio.space/companies/flyte-aviation/) VJET - [InfuSystem Holdings](https://aibio.space/companies/infusystem/) INFU - [Envista Holdings](https://aibio.space/companies/envista/) NVST - [Merck & Company](https://aibio.space/companies/merck-mrk-nyse/) MRK - [Electromed](https://aibio.space/companies/electromed/) ELMD ## ALCON INC annual financials | Line | FY2010 | FY2009 | |---|---|---| | Research and development | [$747.0 million](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | [$665.0 million](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | | Net income (loss) | [$2.21 billion](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | [$2.01 billion](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | | Cash from operations | [$2.38 billion](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | [$2.42 billion](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | | Cash and equivalents | [$2.52 billion](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | [$3.01 billion](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | | Short-term investments | [$889.0 million](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | [$479.0 million](https://www.sec.gov/Archives/edgar/data/1167379/000116737911000037/) | Latest balance sheet, Dec 31, 2010 (20-F): cash and equivalents $2.52 billion, plus short-term investments of $889.0 million, $3.41 billion in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ALCON INC What is the ticker symbol of ALCON INC? ALCON INC trades under the ticker ALC on NYSE. Where is ALCON INC listed? ALCON INC is listed on NYSE. Which country or territory is ALCON INC listed under? Our directory records ALCON INC under United States. Does aibio.space cover ALCON INC? aibio.space lists ALCON INC among 2,820 public biotech companies and publishes its news here as stories appear. Is ALCON INC profitable? ALCON INC reported net income of $2.21 billion for the fiscal year ended Dec 31, 2010, and generated $2.38 billion of cash from operations, per its annual report to the SEC. How much does ALCON INC spend on research and development? $747.0 million in the fiscal year ended Dec 31, 2010, per its annual report. How much cash does ALCON INC have? $3.41 billion in cash and short-term investments at Dec 31, 2010, per its 20-F. ## Investor discussion: ALCON INC Members talk about ALCON INC (ALC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:ALC on TradingView](https://www.tradingview.com/symbols/NYSE-ALC/). ## Listing details ALCON INC is a public biotech or pharmaceutical company listed on NYSE under the ticker ALC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ALCON INC - **Ticker**: ALC - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/alcon/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ALCON INC (ALC) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/alcon/